Ractopamine

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0097825-25-7

Chemical Formula

C18-H23-N-O3

Molecular Weight

301

Therapeutic Category

Growth stimulant

Chemical Names

(R*,R*)-(+-)-4-Hydroxy-α-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]benzenemethanol

(+-)-p-hydroxy-α-[[[3-(p-hydroxyphenyl)-1-methylpropyl]amino]methyl]benzyl alcohol (WHO)

(+-)-R*-p-Hydroxy-α-[[[(R*)-3-(p-hydroxyphenyl)-1-methylpropyl]amino]methyl]benzyl alcohol

(+-)-1-(4-Hydroxyphenyl)-2-[3-(4-hydroxyphenyl)-1-methylpropylamino]ethanol (IUPAC)

1-(4-hydroxyphenyl)-2-[1-methyl-3-(4-hydroxyphenyl)-propylamino]ethanol

4-Hydroxy-α-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]benzenemethanol

Benzenemethanol, 4-hydroxy-α-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-

N-[2-(4-hydroxyphenyl)-2-hydroxyethyl]-1-methyl-3-(4-hydroxyphenyl)propylamine

Foreign Names

• Ractopaminum (Latin)
• Ractopamin (German)
• Ractopamine (French)
• Ractopamina (Spanish)

Generic Names

• HSDB 7441 (IS)
• Ractopamine Hydrochloride (OS: USAN)
• EL 737 (IS: Eli Lilly)
• LY 031537 (IS)

Brand Names

• Optaflexx (Ractopamine and Monensin (veterinary use))
  Elanco Animal Health, United States



• Optaflexx (veterinary use)
  Elanco Animal Health, United States



• Paylean (Ractopamine and Tylosin (veterinary use))
  Elanco Animal Health, United States



• Paylean (veterinary use)
  Elanco Animal Health, Australia; Elanco Animal Health, United States



• Rumensin (Ractopamine and Monensin (veterinary use))
  Elanco Animal Health, United States



• Tylan (Ractopamine and Tylosin (veterinary use))
  Elanco Animal Health, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.